Skip to main content
BrainCited

Resveratrol per Cerebrovascular Health

C

Research suggests resveratrol may improve cerebral blood flow through nitric oxide-mediated vasodilation and activation of neuroprotective SIRT1 pathways. Bioavailability remains a key challenge.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dresveratrol\u0026condition\u003Dcerebrovascular\u002Dhealth'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

In sintesi

Research suggests resveratrol may improve cerebral blood flow through nitric oxide-mediated vasodilation and activation of neuroprotective SIRT1 pathways. Bioavailability remains a key challenge.

Key Study Findings

Systematic Review
Investigating the impact of resveratrol and quercetin on glymphatic function, blood-brain barrier, and neuroglial health: …
Dose: None vs: None Outcome: effects on glymphatic function, BBB permeability, neuroglial health Effetto: None None

Popolazione: experimental models and clinical trials on Alzheimer's, Parkinson's, and multiple sclerosis

Review
Dietary Antioxidants, Polyphenols, and Vascular Health: Insights From Ultrasound Measurement of Carotid Intima-Media Thickness and …
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: older adults and individuals with neurodegenerative disorders

In Vitro
Resveratrol attenuates the CoCl2-induced hypoxia damage by regulation of lysine β-hydroxybutyrylation in PC12 cells.
Dose: None vs: CoCl2-induced hypoxia without resveratrol Outcome: Cell viability and Kbhb modulation under hypoxia Effetto: None None

Popolazione: PC12 rat pheochromocytoma cells

Controlled Clinical Trial
[Verification of resveratrol ameliorating vascular endothelial damage in sepsis-associated encephalopathy through HIF-1α pathway based on …
Dose: 40 or 60 mg/kg vs: CLP group (0.9% NaCl) Outcome: Cerebrovascular endothelial barrier function Effetto: None None

Popolazione: CLP-induced sepsis-associated encephalopathy mice

Systematic Review
The Effects of Resveratrol on Menopausal Cardio-metabolic Changes: A Systematic Review.
Dose: None vs: Placebo or no treatment Outcome: Cardiometabolic changes in menopausal women Effetto: None None

Popolazione: Menopausal women

Key Statistics

8

Studi

600

Partecipanti

Positive

C

Grado

Referenced Papers

International journal of … 2021 50 citazioni
Oxidative medicine and … 2017 87 citazioni
Integrative medicine research 2014 51 citazioni
Annals of the … 2013 31 citazioni
Ageing research reviews 2010 228 citazioni
Genes & nutrition 2010 64 citazioni
Journal of cardiovascular … 2009 297 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
150-500 mg/day trans-resveratrol
cognitivesupport:
200-500 mg/day

Limite massimo: 5,000 mg/day (highest dose in clinical trials)

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Positive --
None -- Positive --
None -- Positive --
None -- Mixed --
40 or 60 mg/kg -- Positive --
None -- Positive --
None -- Mixed --
250 mg single dose -- Positive 16

Momento migliore per l'assunzione: With meals containing fat; morning preferred

Safety & Side Effects

Effetti collaterali segnalati

  • Gastrointestinal discomfort
  • Headache
  • Diarrhea at high doses

Interazioni note

  • Anticoagulants (may increase bleeding risk)
  • CYP450 substrates (affects drug metabolism)
  • Estrogen-sensitive conditions (weak estrogenic activity)

Livello di assunzione massimo tollerabile: 5,000 mg/day (highest dose in clinical trials)

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Resveratrol help with Cerebrovascular Health?
Based on 8 studies with 600 participants, there is limited but promising evidence that Resveratrol may support Cerebrovascular Health management. Our evidence grade is C (Some Evidence).
How much Resveratrol should I take for Cerebrovascular Health?
Studies have used various dosages. A commonly studied range is 150-500 mg/day trans-resveratrol. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Resveratrol?
Reported side effects may include Gastrointestinal discomfort, Headache, Diarrhea at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Resveratrol and Cerebrovascular Health?
We rate the evidence as Grade C (Some Evidence). This rating is based on 8 peer-reviewed studies with 600 total participants. The overall direction of effect is positive.

Related Evidence

Altri ingredienti per Cerebrovascular Health

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.